No. of Recommendations: 12
This may be the one you are thinking of. This Jim's post is from June 2021.
---------------
https://boards.fool.com/what-stock-or-fund-would-y...https://boards.fool.com/an-equally-weighted-portfo...An equally weighted portfolio of all the stocks covered by Value Line in the industries "Medical Supplies - Invasive (8060)" and "Medical Supplies - Non Invasive (3842)".
I recommend rebalance and reconstituting the portfolio periodically, but it doesn't mean much trading as firms don't change industries quickly.
You could do it annually and get much the same result.
Since 1986, that set has averaged about 55 stocks.
If that's too much typing, limit it to (say) 20 or 30 stocks by choosing the ones with the highest fraction of cash in their market cap.
That way they're probably either immensely profitable or very well funded : )
....
This assumes reconstituting the portfolio every 6 months.
...
If you posted twice a year on the MI board asking for a list, I'm sure someone would oblige.
...
You don't need to have the latest week's issue, as the list changes so slowly.
It still seems to give nice results just checking twice a year.
...
Their larger full entire database, usually called the "Plus" or "Extended" edition, currently has 5657 stocks, but the smaller ones have relatively little information coverage.
I was testing only the subset that have full coverage, those in the traditional "Value Line 1700" stock edition.
If for some reason you can't find the list in the 1700 stock edition, but you have access to the full edition,
you can get the same set by adding the requirement that the stock have a valid "Timeliness" ranking.
That data field exists only for stocks in the standard 1700 stock subscription.
Don't require it to be a good Timeliness ranking, just require that it have one. (anything 1-5).
----------------------------------------------
11/4/2021
https://boards.fool.com/ps-what-is-this-quotrebala...FWIW, to get an idea of what firms it would recommend, this is the current list.
ABT ABMD ADPT ALGN ABC ANGO AVNS BAX BDX BIO BSX CAH CTLT
CRL CNMD COO CRY CUTR XRAY DXCM EW NVST GKOS GMED HAE HRC
HOLX ICUI IDXX ILMN NARI INGN INSP PODD IART ISRG IVC IRTC JNJ
LIVN MASI MCK MDT VIVO NTUS NEOG NVRO NVCR NUVA OMCL PDCO PEN
QDEL RMD HSIC SILK SDC STE SYK SRDX TNDM TFX WST ZBH
My "top 15" picks would be
QDEL ICUI NUVA DXCM NEOG SRDX IVC CUTR NTUS INGN OMCL PODD CRY GKOS IART
No dividends, average 5-year rate of growth of sales per share 13%/year, average cash about 15% of market cap.
==================
As for the return, I think this is an example of what you were asking about:
* Value Line stocks, standard edition (average 1658 stocks)
* Stock has any valid Timeliness rating (average 1512 stocks)
* in those two industries (average 59.4 stocks)
* No dividend (average 32.4 stocks)
* Sales-growth 5 year greater than zero (average 23.4 stocks)
* Equally weight them all, reconstitute and rebalance each two months
* Round trip trading costs estimated at 0.4%
Result Jan 1997 to Nov 1 2021, 21.4%/year.
Screen S&P
1997 1.5 27.9
1998 14.2 34.5
1999 15.2 18.4
2000 34.4 -10.8
2001 53.8 -8.0
2002 5.4 -18.9
2003 56.1 23.0
2004 16.3 8.9
2005 25.3 7.5
2006 2.0 13.8
2007 37.5 1.9
2008 -37.6 -32.9
2009 51.3 25.5
2010 22.0 14.2
2011 2.8 2.5
2012 28.6 17.1
2013 34.2 27.6
2014 29.9 12.9
2015 15.0 1.9
2016 23.8 14.4
2017 37.8 21.8
2018 20.1 -3.5
2019 32.5 29.9
2020 34.8 16.9
2021 17.6 25.2
Average 12.1% better than S&P
---------------------------------
This strategy works very nicely with the "Information Services" and "IT Services" industries, too.
(About 81 matches) (About 38 with a Timeliness)
